Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Operating Expenses | 5,086 | 5,699 | 6,364 | 6,197 | 4,913 |
Operating Income | -5,086 | -5,699 | -6,364 | -6,197 | -4,913 |
Other Income | 59 | 29 | 44 | 49 | 50 |
Pre-tax Income | -5,027 | -5,670 | -6,320 | -6,148 | -4,863 |
Net Income Continuous | -5,027 | -5,670 | -6,320 | -6,148 | -4,863 |
Net Income | $-5,027 | $-5,670 | $-6,320 | $-6,148 | $-4,863 |
EPS Basic Total Ops | -1.00 | -1.50 | -1.50 | -1.80 | -1.20 |
EPS Basic Continuous Ops | -1.00 | -1.45 | -1.56 | -1.67 | -1.32 |
EPS Diluted Total Ops | -1.00 | -1.50 | -1.50 | -1.80 | -1.20 |
EPS Diluted Continuous Ops | -1.00 | -1.45 | -1.56 | -1.67 | -1.32 |
EBITDA(a) | $-4,981 | $-5,595 | $-6,351 | $-6,184 | $-4,900 |